Videos Investors are learning that paying 20X sales is nothing if the growth numbers are right. Articles You May Like Jennifer Arndt Voss Capital wants to maximize shareholder value at International Money Express. How it may play out Op-ed: Here’s why a sale of Bausch + Lomb could lead to a windfall for Bausch Health investors As federal aid ends and enrollment grows, charter schools face challenges Point72’s Steve Cohen is stepping back from trading his own book